Oramed Pharmaceuticals
ORMP
#9068
Rank
C$0.16 B
Marketcap
C$4.24
Share price
6.19%
Change (1 day)
19.25%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): -C$6.83 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are C$2 Million. In 2024 the company made an earning of C$0.48 Million a decrease over its 2023 earnings that were of C$9.81 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$6.83 Million-1503.14%
2024 C$0.48 M-95.05%
2023 C$9.81 M-119.45%
2022 -C$50.46 Million39.17%
2021 -C$36.26 Million73.93%
2020 -C$20.85 Million18.53%
2019 -C$17.59 Million-16.62%
2018 -C$21.1 Million38.32%
2017 -C$15.25 Million12.51%
2016 -C$13.56 Million25.01%
2015 -C$10.85 Million18.18%
2014 -C$9.18 Million39.72%
2013 -C$6.57 Million46.4%
2012 -C$4.49 Million128.32%
2011 -C$1.97 Million-51.47%
2010 -C$4.05 Million35.21%
2009 -C$3 Million
2007 -C$4.71 Million607.04%
2006 -C$0.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-C$0.72 Billion 12,138.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
C$28.71 B-491,978.24%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
C$12.53 B-214,830.06%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
-C$37.97 Million 550.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
-C$94.48 Million 1,518.17%๐Ÿ‡บ๐Ÿ‡ธ USA